Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei-Yu Fang

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Medicine|November 7, 2019
Real-world efficacy and potential mechanism of resistance of icotinib in Asian advanced non-small cell lung cancer with EGFR uncommon mutations: A multi-center studyLei Lei, Wen-Xian Wang, You-Cai Zhu, et al.
Cancer Science|December 13, 2019
Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center studyLei Lei, Wen-Xian Wang, You-Cai Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 20, 2025
Lysosomal Cathepsin S Escape Facilitates Near Infrared Light-Triggered Pyroptosis Via an Antibody-Indocyanine Green ConjugateFan Chen, Xue-Fei Tian, Teng Yang, et al.
Translational Lung Cancer Research|November 19, 2020
Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with <i>EGFR</i> exon 20 insertion mutation: a multicenter studyChun-Wei Xu, Wen-Xian Wang, Dong Wang, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Medicine|November 7, 2019
Real-world efficacy and potential mechanism of resistance of icotinib in Asian advanced non-small cell lung cancer with EGFR uncommon mutations: A multi-center studyLei Lei, Wen-Xian Wang, You-Cai Zhu, et al.
Cancer Science|December 13, 2019
Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center studyLei Lei, Wen-Xian Wang, You-Cai Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 20, 2025
Lysosomal Cathepsin S Escape Facilitates Near Infrared Light-Triggered Pyroptosis Via an Antibody-Indocyanine Green ConjugateFan Chen, Xue-Fei Tian, Teng Yang, et al.
Translational Lung Cancer Research|November 19, 2020
Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with <i>EGFR</i> exon 20 insertion mutation: a multicenter studyChun-Wei Xu, Wen-Xian Wang, Dong Wang, et al.
Pageof 3